0430-0752 : Asacol 400 mg/1 Oral Tablet, Delayed Release
NDC: | 0430-0752 |
Labeler: | Warner Chilcott (Us), LLC |
Product Type: | Human Prescription Drug |
Drug Name: | Asacol |
Dosage Form: | Oral Tablet, Delayed Release |
Application #: | NDA019651 |
Rev. Date: |
Appearance:
Markings: | 0752;DR |
Shapes: |
Capsule |
Colors: |
Brown |
Size (mm): | 14 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 0430-0752-00: 67507 TABLET, DELAYED RELEASE IN 1 DRUM (0430‑0752‑00)
- 0430-0752-27: 12 BOTTLE IN 1 CASE (0430‑0752‑27) > 180 TABLET, DELAYED RELEASE IN 1 BOTTLE
Active Ingredients:
- Mesalamine
Dosage Strength:
- 400 mg
Inactive Ingredients:
- Silicon Dioxide
- Dibutyl Phthalate
- Ferric Oxide Red
- Ferric Oxide Yellow
- Lactose Monohydrate
- Magnesium Stearate
- Methacrylic Acid - Methyl Methacrylate Copolymer (1:2)
- Polyethylene Glycols
- Povidones
- Sodium Starch Glycolate Type a Potato
- Talc
Pharmaceutical Classes:
- Aminosalicylate [EPC]
- Aminosalicylic Acids [Chemical/Ingredient]
Related Products:
Based on records with the same trade name.- 0023-0752 Asacol 400 mg Oral Tablet, Delayed Release by Allergan, Inc.
- 0179-0111 Asacol 400 mg Delayed Release Tablet by Kaiser Foundation Hospitals
- 49349-494 Asacol 400 mg Delayed Release Tablet by Remedyrepack Inc.
- 49349-678 Mesalamine 400 mg Delayed Release Tablet by Remedyrepack Inc.
- 49349-951 Mesalamine 400 mg Delayed Release Tablet by Remedyrepack Inc.
- 49999-969 Asacol 400 mg Delayed Release Tablet by Lake Erie Medical & Surgical Supply Dba Quality Care Products LLC
- 53808-0205 Asacol 400 mg Delayed Release Tablet by State of Florida Doh Central Pharmacy
- 53808-0823 Asacol 400 mg Oral Tablet, Delayed Release by State of Florida Doh Central Pharmacy
- 55154-2305 Asacol 400 mg Delayed Release Tablet by Cardinal Health
- 55154-8607 Asacol 400 mg Delayed Release Tablet by Cardinal Health
- 68084-568 Asacol 400 mg Delayed Release Tablet by American Health Packaging
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0430-0722Next: 0430-0753 >
Related Discussions:
Will PENTASA (mesalamine) contradict diabetes medications
I am taking PENTASA (mesalamine) 500 mg tablets daily (6 tabs daily) and I also use azoran 5 mg two tabs daily. Will it ...
I am taking PENTASA (mesalamine) 500 mg tablets daily (6 tabs daily) and I also use azoran 5 mg two tabs daily. Will it ...
Cheap Purchase of Mesalamine Enemas
I am interested in self-employment. I have Ulcerative Colitis. I need this medication to stay alive. My doctor tells me ... 1 reply
I am interested in self-employment. I have Ulcerative Colitis. I need this medication to stay alive. My doctor tells me ... 1 reply
Asacol benefits
I am a senior and have cut my prescription expense and Asacol was one I had discontinued due to the cost. Now I am suffe... 4 replies
I am a senior and have cut my prescription expense and Asacol was one I had discontinued due to the cost. Now I am suffe... 4 replies
Those Asacol Hd Causes Horseness
Those Asacol Hd Causes Horseness. could it be that with time it could effect my vocal chords? ## Asacol contains the act... 1 reply
Those Asacol Hd Causes Horseness. could it be that with time it could effect my vocal chords? ## Asacol contains the act... 1 reply
Side Effects Of Lialda and compare to Asacol HD
I would like to know of any side effects of Lialda and how the drug compares to Asacol HD? ## Lialda contains the active... 3 replies
I would like to know of any side effects of Lialda and how the drug compares to Asacol HD? ## Lialda contains the active... 3 replies
Asacol (mesalamine) delayed-release tablet
mesalamine delayed-release tablet information...
mesalamine delayed-release tablet information...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.